Stay updated on Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision history updated to add v3.5.0 and remove v3.4.3 from the record history. This is an administrative update to the record-keeping and does not change the study content.
    Difference
    0.1%
    Check dated 2026-03-25T20:55:15.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Version 3.4.3 adds Contacts/Locations, Study Design, Study Status, and Recruitment Status. It also updates the recruitment status to Active, not recruiting on 2026-03-05, replacing the previous Recruiting status.
    Difference
    1%
    Check dated 2026-03-11T17:11:37.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added to the Record History; removed a government funding lapse notice and Revision: v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-11T02:17:41.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Added a government funding notice about the NIH Clinical Center's operating status. Updated the site revision to v3.4.1, replacing the previous v3.4.0 revision.
    Difference
    0.9%
    Check dated 2026-02-03T23:01:18.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    UI changes include a glossary toggle and color-coded indicators for additions and deletions in the study history, with the revision label updated to v3.4.0. The previously listed No FEAR Act data note and the older revision label (v3.3.4) are superseded by the new formatting.
    Difference
    1%
    Check dated 2026-01-27T21:32:15.000Z thumbnail image
  9. Check
    108 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added and the HHS Vulnerability Disclosure link along with Revision: v3.3.2 were removed.
    Difference
    0.2%
    Check dated 2025-12-22T22:23:45.000Z thumbnail image

Stay in the know with updates to Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page.